Skip to content

Migraine and Headache Disease‑Specific Clinical Trials

More research is needed to help find safe and effective treatments for people living with migraine and headache disease. As we are made aware of clinical trials that may be of interest to our community, we will post links on this page.


Biohaven BHV3500-302- adult migraine study (18+), must be diagnosed with migraine >1 year; in last 3 months, must have at least 8 migraines and at least 15 headaches per month  (investigational nasal product).

Satsuma  STS101-007 – adult migraine (18+), experiencing 2-8 migraines per month (investigational nasal spray).

Eli Lilly H8H-MC-LAHV- pediatric migraine study (ages 6-17), must have at least 2-8 moderate-to-severe migraines per month in past 2 months and is as least 33lbs and can swallow a tablet.


Are you living with migraine?

You might be able to help scientists uncover new solutions. By participating in the AbbVie Research Collaborative, you’re partnering with scientists as to help unlock knowledge of migraine disease by sharing your health data and migraine experience. Joining is easy and free.

Scroll To Top